Search research articles
Contact Us
Filters
Showing results (21-30 of 78) with videos related to
Page
of 8
Sort By:
Pharmacoeconomics
|
December 13, 2016
Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and Medicine
Mike Paulden, James F O'Mahony, Christopher McCabe
Pharmacoeconomics
|
March 23, 2016
Cancer Drugs Fund 2.0: A Missed Opportunity?
Christopher McCabe, Ash Paul, Greg Fell, et al.
BMJ (Clinical Research Ed.)
|
December 24, 2009
Screening for postnatal depression in primary care: cost effectiveness analysis
Mike Paulden, Stephen Palmer, Catherine Hewitt, et al.
Pharmacoeconomics
|
November 22, 2014
Value-based reimbursement decisions for orphan drugs: a scoping review and decision framework
Mike Paulden, Tania Stafinski, Devidas Menon, et al.
Pharmacoeconomics
|
May 11, 2017
A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models
Chase Hollman, Mike Paulden, Petros Pechlivanoglou, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 19, 2025
Return-on-Investment in Health Economic Evaluation: An Exploratory Analysis
Mina Alizadehsadrdaneshpour, Jacob Smith, Mike Paulden, et al.
International Journal of Technology Assessment in Health Care
|
July 10, 2025
A systematic review of health economic evaluation quality assessment instruments for medical devices
Ilke Akpinar, Ali Unsal, Mike Paulden, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 30, 2026
Response to "Concept or Calculation?" Reassessing the Foundations of ROI Thresholds in Health Economic Evaluation
Mina Alizadehsadrdaneshpour, Jacob Smith, Mike Paulden, et al.
Pharmacoeconomics
|
November 22, 2014
Objectivity and equity: clarity required. A response to Hill and Olson
Mike Paulden, James F O'Mahony, Anthony J Culyer, et al.
Pharmacoeconomics
|
November 23, 2020
Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier
Christopher McCabe, Giovanni Tramonti, Andrew Sutton, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 78) with videos related to
Sort By:
Page
of 8
Pharmacoeconomics
|
December 13, 2016
Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and Medicine
Mike Paulden, James F O'Mahony, Christopher McCabe
Pharmacoeconomics
|
March 23, 2016
Cancer Drugs Fund 2.0: A Missed Opportunity?
Christopher McCabe, Ash Paul, Greg Fell, et al.
BMJ (Clinical Research Ed.)
|
December 24, 2009
Screening for postnatal depression in primary care: cost effectiveness analysis
Mike Paulden, Stephen Palmer, Catherine Hewitt, et al.
Pharmacoeconomics
|
November 22, 2014
Value-based reimbursement decisions for orphan drugs: a scoping review and decision framework
Mike Paulden, Tania Stafinski, Devidas Menon, et al.
Pharmacoeconomics
|
May 11, 2017
A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models
Chase Hollman, Mike Paulden, Petros Pechlivanoglou, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 19, 2025
Return-on-Investment in Health Economic Evaluation: An Exploratory Analysis
Mina Alizadehsadrdaneshpour, Jacob Smith, Mike Paulden, et al.
International Journal of Technology Assessment in Health Care
|
July 10, 2025
A systematic review of health economic evaluation quality assessment instruments for medical devices
Ilke Akpinar, Ali Unsal, Mike Paulden, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 30, 2026
Response to "Concept or Calculation?" Reassessing the Foundations of ROI Thresholds in Health Economic Evaluation
Mina Alizadehsadrdaneshpour, Jacob Smith, Mike Paulden, et al.
Pharmacoeconomics
|
November 22, 2014
Objectivity and equity: clarity required. A response to Hill and Olson
Mike Paulden, James F O'Mahony, Anthony J Culyer, et al.
Pharmacoeconomics
|
November 23, 2020
Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier
Christopher McCabe, Giovanni Tramonti, Andrew Sutton, et al.
Page
of 8